SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Attention Disorders
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hoeppner, J.B.
Right arrow Articles by Trommer, B.L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hoeppner, J.B.
Right arrow Articles by Trommer, B.L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A clinical protocol for determining methylphenidate dosage levels in ADHD

J.B. Hoeppner

J.B. Hale

A.M. Bradley

M. Byrnes

D.L. Coury

L. Lennie

B.L. Trommer

Despite the widespread use of methylphenidate (MPH) in the treatment of children with Attention Deficit Hyperactivity Disorder (ADHD), physicians often must rely on anecdotal observations and subjective reports to titrate MPH regimens. Many double-blind placebo-controlled medication trials have demonstrated treatment efficacy; however, the development of an effective clinical protocol that is reliably sensitive to dose-response relationships and can be used in office practice remains elusive. Using a double-blind placebo clinical protocol, and rank order analysis of instruments sensitive to ADHD symptoms, the MPH response patterns of 50 children with ADHD were analyzed using repeated measures multivariate analysis of variance. Several instru ments were sensitive in predicting response, and others revealed trends in the expected direction. The rank order rating analyses revealed robust differences between active drug conditions and placebo. Using cognitive rank order ratings, linear and quadratic MPH response patterns were identified, with the best dose for each group significantly different from that obtained for all other conditions.

Journal of Attention Disorders, Vol. 2, No. 1, 19-30 (1997)
DOI: 10.1177/108705479700200102


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Learn DisabilHome page
J. B. Hale, J.-A. B. Hoeppner, M. B. DeWitt, D. L. Coury, D. G. Ritacco, and B. Trommer
Evaluating Medication Response in ADHD: Cognitive, Behavioral, and Single-Subject Methodology
J Learn Disabil, November 1, 1998; 31(6): 595 - 607.
[Abstract] [PDF]



Advertisement